Dark

DYN
Dyne Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Jul 31, 2026 3:59:55 PM EDT

25.16USD-2.235%(-0.57)1,824,987

21.40Bid 28.52Ask 7.12Spread

Pre-market

Jul 31, 2026 9:28:30 AM EDT

25.84USD+0.428%(+0.11)1,118

After-hours

Jul 31, 2026 4:04:30 PM EDT

25.00USD-0.616%(-0.16)409,810

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

4.69B

Headquarters

Waltham, MA, USA

Industry

Biotechnology

AES CNP NRG ALE XLU

DYN Stats

Avg. Vol. 10 Day

3,403,492

Avg. Vol. 30 Day

2,783,701

Employees

2,489

Market Cap

4,690,650,895

Shares Out.

186,358,796

On/Off Exchange

59%/41%

6 Month Beta

1.97

1 Year Beta

1.97

2 Year Beta

1.78

3 Year Beta

1.71

52 Week Low

9.57

52 Week High

26.26

SMA50

20.89

SMA200

19.05

1 Week

+2.99%

1 Month

+15.51%

3 Month

+44.74%

6 Month

+40.69%

1 Year

+155.53%

2 Year

-41.34%

5 Year

+39.29%

Profile

dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts.

DYN Stock Summary

Dyne Therapeutics, Inc. Common Stock (NASDAQ:DYN) stock price today is $25.16, and today's volume is 1,824,987. DYN is down -2.235% today. The 30 day average volume is 2,783,701. DYN market cap is 4.69B with 186,358,796 shares outstanding.